verywellhealth18 天
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
Hindustan Times19 天
NASA astronaut shares pic of Maha Kumbh from space: ‘Largest human gathering in the world ...
The largest human gathering in the world is well lit,” Pettit wrote. The pictures drew admiration from his followers. “The 2025 Maha Kumbh Mela at the Ganges River, seen from the International ...
RTE Online22 天
In Pictures: Destruction across country as Storm Éowyn leaves its mark
The roof of the Donegal Primary Care Centre in Donegal Town was badly damaged (Pic below: Courtesy Siobhán McGowan) An ice skating facility in Blanchardstown (below) has been destroyed after ...
India Today23 天
US FDA approves new nasal spray for depression treatment: All about it
Johnson & Johnson's nasal spray received US FDA approval The nasal spray is used for the treatment of major depressive disorder The drug brought in sales of $780 million in 2024 The US Food and Drug ...
Indiatimes24 天
PIC: Saif Ali Khan hugs and thanks the auto driver who helped him during the stabbing attack
Bollywood actor Saif Ali Khan had a heartfelt reunion with an auto driver who rushed him to the hospital during a knife attack incident. Saif expressed his deep gratitude, emphasizing the ...
healthday24 天
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
The Daily Beast24 天
New Nasal Spray to Treat Depression Gets FDA Approval
Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...
U.S. News & World Report24 天
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
Newsweek24 天
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
New York Post24 天
J&J’s ketamine-derived nasal spray approved by FDA to treat depression
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
Gizmodo24 天
Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...